check_circleStudy Completed

Migraine

Bayer Identifier:

Trial_0159

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Nimodipine (Bay e 9736) in migraine prophylaxis

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

17 - 52 Years
  • -

  • -

Trial summary

Enrollment Goal
25
Trial Dates
March 1980 - August 1980
Phase
Phase 4
Could I Receive a placebo
N/A
Products
Nimotop (Nimodipine, BAYE9736)
Accepts Healthy Volunteer
N/A

Trial design

Test of the effectiveness and tolerance of nimodipine (Bay e 9736) in migraine prophylaxis.
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
Treatment
Allocation
N/A
Blinding
N/A
Assignment
Single Group Assignment
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.